These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1640 related items for PubMed ID: 33805843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.
    Alarcón-Arís D, Recasens A, Galofré M, Carballo-Carbajal I, Zacchi N, Ruiz-Bronchal E, Pavia-Collado R, Chica R, Ferrés-Coy A, Santos M, Revilla R, Montefeltro A, Fariñas I, Artigas F, Vila M, Bortolozzi A.
    Mol Ther; 2018 Feb 07; 26(2):550-567. PubMed ID: 29273501
    [Abstract] [Full Text] [Related]

  • 3. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.
    Alarcón-Arís D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferrés-Coy A, Ruiz-Bronchal E, Galofré M, Paz V, Campa L, Revilla R, Montefeltro A, Kordower JH, Vila M, Artigas F, Bortolozzi A.
    EBioMedicine; 2020 Sep 07; 59():102944. PubMed ID: 32810825
    [Abstract] [Full Text] [Related]

  • 4. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.
    Taylor TN, Potgieter D, Anwar S, Senior SL, Janezic S, Threlfell S, Ryan B, Parkkinen L, Deltheil T, Cioroch M, Livieratos A, Oliver PL, Jennings KA, Davies KE, Ansorge O, Bannerman DM, Cragg SJ, Wade-Martins R.
    Neurobiol Dis; 2014 Feb 07; 62():193-207. PubMed ID: 24121116
    [Abstract] [Full Text] [Related]

  • 5. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
    Rauschenberger L, Behnke J, Grotemeyer A, Knorr S, Volkmann J, Ip CW.
    Neurobiol Dis; 2022 Sep 07; 171():105798. PubMed ID: 35750147
    [Abstract] [Full Text] [Related]

  • 6. The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.
    He Q, Zhang S, Wang J, Ma T, Ma D, Wu L, Zhou M, Zhao L, Chen Y, Liu J, Chen W.
    Mol Neurobiol; 2024 Sep 07; 61(9):7046-7065. PubMed ID: 38367134
    [Abstract] [Full Text] [Related]

  • 7. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J, Luo S, Zhang J, Yu T, Fu Z, Zheng Y, Xu X, Liu C, Fan M, Zhang Z.
    Neurobiol Dis; 2021 Jan 07; 148():105218. PubMed ID: 33296726
    [Abstract] [Full Text] [Related]

  • 8. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
    Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C.
    Neuroscience; 2011 Apr 28; 180():280-92. PubMed ID: 21333719
    [Abstract] [Full Text] [Related]

  • 9. Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.
    Behere A, Thörnqvist PO, Winberg S, Ingelsson M, Bergström J, Ekmark-Lewén S.
    J Neurosci Res; 2021 Oct 28; 99(10):2525-2539. PubMed ID: 34292621
    [Abstract] [Full Text] [Related]

  • 10. A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein.
    Vicario M, Cieri D, Vallese F, Catoni C, Barazzuol L, Berto P, Grinzato A, Barbieri L, Brini M, Calì T.
    Cell Death Dis; 2019 Nov 12; 10(11):857. PubMed ID: 31719530
    [Abstract] [Full Text] [Related]

  • 11. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z, Ahlers-Dannen KE, Spicer MM, Yang J, Alberico S, Stevens HE, Narayanan NS, Fisher RA.
    JCI Insight; 2019 May 23; 5(13):. PubMed ID: 31120439
    [Abstract] [Full Text] [Related]

  • 12. Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.
    Okuda S, Uemura N, Sawamura M, Taguchi T, Ikuno M, Uemura MT, Yamakado H, Takahashi R.
    Neurotherapeutics; 2022 Jan 23; 19(1):289-304. PubMed ID: 34935120
    [Abstract] [Full Text] [Related]

  • 13. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
    Rocha EM, Smith GA, Park E, Cao H, Brown E, Hayes MA, Beagan J, McLean JR, Izen SC, Perez-Torres E, Hallett PJ, Isacson O.
    Neurobiol Dis; 2015 Oct 23; 82():495-503. PubMed ID: 26392287
    [Abstract] [Full Text] [Related]

  • 14. Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice.
    Pavia-Collado R, Rodríguez-Aller R, Alarcón-Arís D, Miquel-Rio L, Ruiz-Bronchal E, Paz V, Campa L, Galofré M, Sgambato V, Bortolozzi A.
    Int J Mol Sci; 2022 Feb 04; 23(3):. PubMed ID: 35163729
    [Abstract] [Full Text] [Related]

  • 15. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S, Melis V, Horsley D, Rickard JE, Riedel G, Fadda P, Scherma M, Harrington CR, Wischik CM, Theuring F, Schwab K.
    Behav Brain Res; 2018 Feb 26; 339():153-168. PubMed ID: 29180135
    [Abstract] [Full Text] [Related]

  • 16. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion In Vitro and Delays Its Aggregation in rAAV-Based Rat Models of Parkinson's Disease.
    Nakamura Y, Arawaka S, Sato H, Sasaki A, Shigekiyo T, Takahata K, Tsunekawa H, Kato T.
    J Neurosci; 2021 Sep 01; 41(35):7479-7491. PubMed ID: 34290084
    [Abstract] [Full Text] [Related]

  • 17. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease.
    Kilpeläinen T, Julku UH, Svarcbahs R, Myöhänen TT.
    Sci Rep; 2019 Nov 22; 9(1):17382. PubMed ID: 31758049
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N, Rao SP, Kalivendi SV.
    Free Radic Biol Med; 2019 May 01; 135():28-37. PubMed ID: 30796974
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.